货号:GS40601
Resugosbart (SHR-1222) is a humanized IgG4 kappa monoclonal antibody targeting sclerostin (SOST). It blocks sclerostin’s inhibition of the Wnt/β-catenin signaling pathway, thereby promoting bone formation and increasing bone mineral density. It is being developed for the treatment of osteoporosis and other bone loss disorders.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯